Ron Conway, a well-known venture capitalist with SV Angel, has announced that he is stepping back from some of his activities due to a recent diagnosis of a rare form of cancer. In a post on X, Conway stated that he will focus on treatments while continuing to support founders backed by SV Angel at critical points in their businesses. His sons Topher and Ronny are taking over key responsibilities, with Topher having made investment decisions for the firm for nearly a decade and Ronny joining as a managing partner in 2024.
According to Conway, his diagnosis will not affect the operations of SV Angel, which he described as "unchanged". The firm's focus remains on partnering with founders building innovative technologies, including AI. Despite his own health challenges, Conway expressed optimism about his treatment and recovery prospects.
Conway has been a prominent figure in Silicon Valley for many years, investing in numerous successful startups and supporting the development of new technology. He credits his team of UCSF doctors in San Francisco for their exceptional care and support.
The news comes as a surprise to many in the tech community, where Conway is widely respected for his entrepreneurial spirit and investment expertise. His ability to continue supporting founders while undergoing treatment has been hailed as testament to his dedication to the startup ecosystem.
